Table 2.
Frequency distribution of 10-year predicted CVD incidence and mortality using various risk prediction models, in incremental risk categories of 10%
| Risk categories | |||||
|---|---|---|---|---|---|
| 0–9% | 10–19% | 20–29% | 30–39% | ≥40% | |
| Framingham 10-year predicted risk for CVD incidence18 | 2936 (67.0%) | 764 (17.4%) | 417 (9.5%) | 179 (4.1%) | 89 (2.0%) |
| Framingham 10-year predicted risk for CVD death18 | 4354 (99.3%) | 29 (0.7%) | 2 (0%) | 0 (0%) | 0 (0%) |
| SCORE-HIGH 10-year predicted risk for CVD death19 | 4318 (98.5%) | 53 (1.2%) | 9 (0.2%) | 4 (0.1%) | 1 (0%) |
| GCVD 10-year predicted risk for CVD incidence and death20 | 3738 (85.2%) | 503 (11.5%) | 109 (2.5%) | 21 (0.5%) | 14 (0.3%) |
| SGCVD 10-year predicted risk for CVD incidence and death20 | 3809 (85.7%) | 519 (11.7%) | 90 (2.0%) | 19 (0.4%) | 9 (0.2%) |
Counts and percentages of women were presented.
CVD, cardiovascular disease; GCVD, general cardiovascular disease risk score model; SCORE-HIGH, SCORE risk chart for high-risk regions; SGCVD, simplified general cardiovascular disease risk score model.